Medicare Advantage Rule Changes: What the Industry Won't Tell You

The Centers for Medicare & Medicaid Services (CMS) has finalized its Calendar Year 2027 rule changes for Medicare Advantage (MA) and Part D plans, set to take effect June 1, 2026

"On April 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a final rule revising the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), and Medicare Cost Plan Program. The Contract Year (CY) 2027 MA and Part D final rule aims to improve quality and access to care for people enrolled in these programs by finalizing updates to MA and Part D Star Ratings quality measurements and streamlining certain enrollment processes."

. While framed as an effort to improve quality and access, these changes will impact beneficiaries. Key updates include revisions to MA and Part D Star Ratings quality measurements, aimed at better reflecting plan performance

"On April 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a final rule revising the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), and Medicare Cost Plan Program. The Contract Year (CY) 2027 MA and Part D final rule aims to improve quality and access to care for people enrolled in these programs by finalizing updates to MA and Part D Star Ratings quality measurements and streamlining certain enrollment processes."

. Additionally, the rule addresses supplemental benefits administration and Part D coverage, potentially affecting the scope and cost of services available to beneficiaries

"Earlier this month, CMS released the Final Part C and D Rule for 2027, which revises Medicare Advantage (MA) and Part D regulations to implement various policy changes."

. The goal, according to CMS, is to foster a sustainable and stable MA program that offers choice and acts as a responsible steward of taxpayer funds

"The Centers for Medicare & Medicaid Services released the Calendar Year (CY) 2027 Medicare Advantage (MA) and Part D Rate Announcement today to improve payment accuracy across both programs. The finalized policies also advance CMS' vision of a sustainable and stable MA program that offers choice to Medicare beneficiaries and is a responsible steward to taxpayers."

. However, the devil is often in the details of how these broad strokes translate to individual plan offerings and out-of-pocket expenses.

The finalized 2027 rule places a significant emphasis on updating Medicare Advantage and Part D Star Ratings quality measurements

"On April 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a final rule revising the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), and Medicare Cost Plan Program. The Contract Year (CY) 2027 MA and Part D final rule aims to improve quality and access to care for people enrolled in these programs by finalizing updates to MA and Part D Star Ratings quality measurements and streamlining certain enrollment processes."

. The conventional wisdom is that higher star ratings mean better care. However, this revision could become a complex game of metrics. CMS is refining how plans are evaluated, potentially rewarding those who excel in specific areas. But for beneficiaries, this might mean plans are optimizing for the rating system rather than comprehensively improving care. The true impact will be seen in whether these updated metrics genuinely lead to better health outcomes or simply a more favorable score on paper, a distinction the industry is adept at blurring.

Changes to supplemental benefits administration are a critical, yet often opaque, aspect of this new rule

"Earlier this month, CMS released the Final Part C and D Rule for 2027, which revises Medicare Advantage (MA) and Part D regulations to implement various policy changes."

. While CMS aims to streamline processes, beneficiaries need to scrutinize what 'streamlining' means for their specific benefits. Will it lead to more consistent access to services like dental, vision, or hearing, or could it be a pathway for plans to reduce coverage or impose stricter eligibility requirements? The industry has a history of reinterpreting benefit categories, and beneficiaries should ask direct questions about how specific benefits, such as transportation or home safety modifications, will be administered under the new framework. Don't just look at the plan's star rating; examine the fine print on what's actually covered and how easily you can access it.

The rule also touches upon Part D coverage, a perennial concern for seniors managing prescription costs. While specific details on how coverage will be altered aren't fully elaborated in initial summaries, any changes to the framework for prescription drug benefits warrant close attention. Beneficiaries should anticipate potential shifts in preferred drug lists, formulary structures, or even the definition of what constitutes 'covered' drugs. Given the broader context of payment adjustments

"The 2027 Advance Notice dropped January 26, 2026. The major headline is a near-zero rate increase: 0.09% versus roughly 5% last year. LinkedIn is full of stock charts and hot takes from brilliant industry veterans, but, to me, the near-zero rate isn't the story. The story is how CMS got there and what it signals about where Medicare Advantage economics are headed."

, plans might look to manage their Part D liabilities, which could translate to higher out-of-pocket costs for certain medications. It's crucial to understand how these finalized rules might affect your personal drug regimen and associated expenses.